Intravenous immunoglobulin therapy in two patients with myasthenia gravis and pemphigus vulgaris

Acta Myologica

Volumn 28, Issue 3, 2009, Pages 101-102

  Rakocevic Stojanovic, Vidosava ^a   Rakocevic I ^a   Peric S ^a   Lavrnic D ^a  

^a UCC   (Serbia)

Author keywords

Intravenous immunoglobulins; Myasthenia gravis; Pemphigus vulgaris

Indexed keywords

ANTINUCLEAR ANTIBODY; AZATHIOPRINE; CHOLINERGIC RECEPTOR ANTIBODY; CORTICOSTEROID; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; PREDNISOLONE; PYRIDOSTIGMINE;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CASE REPORT; CORTICOSTEROID THERAPY; DIPLOPIA; DISEASE DURATION; DRUG EFFICACY; FATIGUE; FEMALE; HUMAN; IMMUNOTHERAPY; MYASTHENIA GRAVIS; PEMPHIGUS VULGARIS; REMISSION; THYMECTOMY; THYMUS HYPERPLASIA; TREATMENT DURATION;

ADULT; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; MIDDLE AGED; MYASTHENIA GRAVIS; PEMPHIGUS; SKIN;

EID: 77951831424     PISSN: 11282460     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Huh WK, Tada J, Fujimoto W, et al. Thyroid gland tumor, pemphigus foliaceus and myasthenia gravis in the daughter of a woman with myasthenia gravis. Clinical & Experimental Dermatology 2001;26:504-507 (Pubitemid 32955461)
2. Maize JC, Dobson RL, Ptovost TT. Pemphigus and myasthenia gravis. Arch Dermatol 1975;111:1334-1339
3. Shere Y, Bar-Dayan Y, Shoenfeld Y. Thymoma thymic hyperplasia, thymectomy and autoimmune diseases. Int J Oncol 1997;10:939-943 (Pubitemid 27210159)
4. Patten SF, Dijkstra JWE. Review associations of pemphigus and autoimmune disease with malignancy or thymoma. Int J Dermatol 1994;33:836-842
5. Grando SA. New approaches to the treatment of pemphigus. J Investig Dermatol Symp Proc 2004;9:84-91.